Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04785079 · ClinicalTrials.gov registry record · NA

Instrument Assisted Soft Tissue Mobilization Effect on Blood Flow

A NA study of Asymptomatic Condition, sponsored by Florida Gulf Coast University.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT04785079 is a NA study of Asymptomatic Condition that has completed, run by Florida Gulf Coast University. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04785079, a NA study of Asymptomatic Condition, has completed, sponsored by Florida Gulf Coast University.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

This study is designed to evaluate the short term change in blood flow in the superficial human tissue layers after the application of 3 min Graston instrumented assisted soft tissue mobilization on the plantar aspect of the foot and the trapezius muscle.

Conditions Studied

Interventions

  • PROCEDURE Graston Instrument assisted Soft tissue Mobilization

Study Locations (1)

Florida

  • Florida Gulf Coast University - Fort Myers

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2020-08-01
Est. Completion 2022-03-01
Phase NA

Sponsor

Florida Gulf Coast University

11 total trials

What the Registry Record Tells You About NCT04785079

The ClinicalTrials.gov registry entry for NCT04785079 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida Gulf Coast University, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asymptomatic Condition appearing as the primary indexed condition, and to 1 intervention - of which Graston Instrument assisted Soft tissue Mobilization is the first listed.

NCT04785079 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04785079 about?

NCT04785079 is a clinical study titled "Instrument Assisted Soft Tissue Mobilization Effect on Blood Flow". This study is designed to evaluate the short term change in blood flow in the superficial human tissue layers after the application of 3 min Graston instrumented assisted soft tissue mobilization on the plantar aspect of the foot and the trapezius muscle.

What is the current status of trial NCT04785079?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2020-08-01. Estimated completion is 2022-03-01.

What conditions does trial NCT04785079 study?

This clinical trial studies the following conditions: Asymptomatic Condition.

What interventions are being tested in trial NCT04785079?

The interventions under investigation include: Graston Instrument assisted Soft tissue Mobilization (PROCEDURE).

Who is sponsoring clinical trial NCT04785079?

This trial is sponsored by Florida Gulf Coast University, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04785079 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.